Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Préoccupations en ce qui concerne la recommandation contre la prescription d’inhibiteurs sélectifs de la recapture de la sérotonine dans la Ligne directrice canadienne pour la prise en charge clinique de la consommation d’alcool à risque élevé et du trouble d’utilisation de l’alcool.
Bahji A, Danilewitz M, Sloan M, Tang V, Crockford D. Bahji A, et al. CMAJ. 2024 May 20;196(19):E685-E686. doi: 10.1503/cmaj.149917-l-f. CMAJ. 2024. PMID: 38772607 Free PMC article. French. No abstract available.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes.
Lam RW, Kennedy SH, Adams C, Bahji A, Beaulieu S, Bhat V, Blier P, Blumberger DM, Brietzke E, Chakrabarty T, Do A, Frey BN, Giacobbe P, Gratzer D, Grigoriadis S, Habert J, Ishrat Husain M, Ismail Z, McGirr A, McIntyre RS, Michalak EE, Müller DJ, Parikh SV, Quilty LS, Ravindran AV, Ravindran N, Renaud J, Rosenblat JD, Samaan Z, Saraf G, Schade K, Schaffer A, Sinyor M, Soares CN, Swainson J, Taylor VH, Tourjman SV, Uher R, van Ameringen M, Vazquez G, Vigod S, Voineskos D, Yatham LN, Milev RV. Lam RW, et al. Among authors: bahji a. Can J Psychiatry. 2024 May 6:7067437241245384. doi: 10.1177/07067437241245384. Online ahead of print. Can J Psychiatry. 2024. PMID: 38711351 Free article. Review.
Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial.
Bastien G, Abboud A, McAnulty C, Elkrief L, Ledjiar O, Socias ME, Le Foll B, Bahji A, Brissette S, Marsan S, Jutras-Aswad D. Bastien G, et al. Among authors: bahji a. J Dual Diagn. 2024 Apr 5:1-12. doi: 10.1080/15504263.2024.2329267. Online ahead of print. J Dual Diagn. 2024. PMID: 38580298
Training in Substance Use Disorders, Part 2: Updated Curriculum Guidelines.
Crockford D, Bahji A, Schutz C, Brasch J, Buckley L, Danilewitz M, Dubreucq S, Mak M, George TP. Crockford D, et al. Among authors: bahji a. Can J Psychiatry. 2024 Jun;69(6):457-478. doi: 10.1177/07067437241232456. Epub 2024 Mar 27. Can J Psychiatry. 2024. PMID: 38533564 No abstract available.
106 results